Disposition of 1610 shares by David Lehman of Pulmonx Corp at 6.18 subject to Rule 16b-3
LUNG Stock | USD 8.62 0.60 6.51% |
Roughly 70% of Pulmonx Corp's investor base is looking to short. The analysis of overall sentiment of trading Pulmonx Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Pulmonx Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Pulmonx Corp stock news signals to limit their universe of possible portfolio assets.
Pulmonx |
Filed transaction by Pulmonx Corp Officer: General Counsel. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at globenewswire.com
![]() |
Pulmonx Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Pulmonx Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Pulmonx Corp Fundamental Analysis
We analyze Pulmonx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulmonx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulmonx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
Pulmonx Corp is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Pulmonx Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pulmonx Corp stock to make a market-neutral strategy. Peer analysis of Pulmonx Corp could also be used in its relative valuation, which is a method of valuing Pulmonx Corp by comparing valuation metrics with similar companies.
Peers
Pulmonx Corp Related Equities
APYX | Apyx Medical | 5.07 | ||||
INGN | Inogen | 4.78 | ||||
NPCE | Neuropace | 3.11 | ||||
AXGN | Axogen | 2.99 | ||||
SIBN | Si Bone | 1.74 | ||||
LIVN | LivaNova PLC | 1.71 | ||||
KIDS | Orthopediatrics Corp | 1.44 | ||||
OFIX | Orthofix Medical | 0.99 | ||||
ELMD | Electromed | 0.78 | ||||
RXST | Rxsight | 0.53 | ||||
IRMD | Iradimed | 0.02 | ||||
CNMD | CONMED | 0.44 | ||||
ITGR | Integer Holdings | 0.48 | ||||
SRDX | SurModics | 1.26 | ||||
TMCI | Treace Medical | 2.08 |
Complementary Tools for Pulmonx Stock analysis
When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |